Search Results

Mood stabilisers in hepatic impairment6,7,80 Prescribing in hepatic and renal impairment CHAPTER 8 Mood stabilisers in hepatic impairment6,7,80 Recommendations for the use of mood-­stabilising medications in hepatic impairment are summarised in Table 8.3. Tabl...

Stimulants in hepatic impairment6,7,82

Sedatives in hepatic impairment 760 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 8 Stimulants in hepatic impairment6,7,82 Recommendations for the use of stimulant medications in hepatic impairment are ­outlined in Table 8.4. Sedatives in hepatic ...

Other psychotropics in hepatic impairment

Summary of recommended psychotropics in hepatic impairment Prescribing in hepatic and renal impairment CHAPTER 8 Other psychotropics in hepatic impairment Table 8.6 gives a summary of other psychotropics recommended in hepatic impairment. Summary of recommende...

Drug-induced hepatic damage 762 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 8 Drug-­induced hepatic damage Hy’s rule is defined as alanine aminotransferase (ALT) more than three times the upper limit of normal combined with serum bilirubin more ...

References Prescribing in hepatic and renal impairment CHAPTER 8 References Slim M, et al. Hepatic safety of atypical antipsychotics: current evidence and future directions. Drug Saf 2016; 39:925–943. Todorović Vukotić N, et al. Antidepressants-­ and antips...

Renal impairment

General principles of prescribing in renal impairment 766 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 8 Renal impairment Using drugs in patients with renal impairment needs careful consideration. This is partly because some drugs are nephrotoxic...

Stage of renal impairment Prescribing in hepatic and renal impairment CHAPTER 8 Stage of renal impairment Figure 8.1 indicates how to classify the stage of renal impairment.2 Box 8.2  Cockroft and Gault equation* CrCl ml/ F age in years ideal body weight kg Se...

Notes 768 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 8 Notes ■ ■Monitor decline in renal function over a considerable period as a 30% change over 2 years is associated with a fivefold increase in risk of end stage renal disease. Chronic kidney ...

Summary of recommended psychotropics in renal impairment Prescribing in hepatic and renal impairment CHAPTER 8 Summary of recommended psychotropics in renal impairment Where renal function declines while on existing drug treatment, rule out existing drugs as a...

References 780 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 8 References National Institute for Health and Care Excellence. Chronic kidney disease: assessment and management NICE Guideline [NG203]. 2021 (last checked May 2024); https://www.nice....

Borderline personality disorder (BPD) The Maudsley® Prescribing Guidelines in Psychiatry, Fifteenth Edition. David M. Taylor, Thomas R. E. Barnes and Allan H. Young. © 2025 David M. Taylor. Published 2025 by John Wiley & Sons Ltd. Chapter 9 Borderline personal...

Drug treatments of BPD 788 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 9 In 2009 the UK National Institute for Health and Care Excellence (NICE)8 ­recommended that: ■ ■Drug treatment should not be used routinely for BPD or for the individual sym...

Management of crisis 790 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 9 Ketamine A small RCT investigating the effects of one infusion of ketamine (vs midazolam) found more improvement in socio-­occupational functioning in the ketamine group at d...

References Drug treatment of other psychiatric conditions CHAPTER 9 References Winsper C, et al. The prevalence of personality disorders in the community: a global systematic review and meta-­analysis. Br J Psychiatry 2020; 216:­69–­78. Leichsenring F, et al....

Eating disorders